Ischemic Preconditioning Affects Interleukin Release in Fatty Livers of Rats Undergoing Ischemia/Reperfusion

Hepatology

Volumn 39, Issue 3, 2004, Pages 688-698

  Serafín, Anna ^a   Roselló Catafau, Joan ^a   Prats, Neus ^b   Gelpí, Emilio ^a   Rodés, Joan ^c   Peralta, Carmen ^a  

^a INSTITUT D INVESTIGACIONS BIOMÈDIQUES AUGUST PI I SUNYER IDIBAPS   (Spain)

^b UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^c UNIVERSITY OF BARCELONA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; INTERLEUKIN 1; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 10; INTERLEUKIN 10 ANTIBODY; INTERLEUKIN 1BETA; NITRIC OXIDE; POLYCLONAL ANTIBODY;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOSYNTHESIS; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; EVALUATION; EXPERIMENTAL MODEL; FATTY LIVER; HISTOPATHOLOGY; LIVER INJURY; LIVER ISCHEMIA; LIVER LEVEL; LIVER PROTECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN FUNCTION; RAT; RAT STRAIN; REPERFUSION INJURY;

ANIMALS; ANTIBODIES; DOSE-RESPONSE RELATIONSHIP, DRUG; FATTY LIVER; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; INTERLEUKIN-1; INTERLEUKIN-10; ISCHEMIC PRECONDITIONING; LIVER CIRCULATION; NITRIC OXIDE; RATS; RATS, ZUCKER; REPERFUSION INJURY; SIALOGLYCOPROTEINS;

EID: 1542515162     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.20089     Document Type: Article

References (42)

1. Behrns KE, Tsiotos GG, DeSouza NF, Krishna MK, Ludwig J, Nagorney DM. Hepatic steatosis as a potential risk factor for major hepatic resection. J Gastrointest Surg 1998;2:292-298.
2. Selzner M, Clavien PA. Resection of liver tumors: special emphasis on neoadjuvant and adjuvant therapy. In: Clavien PA, ed. Malignant Liver Tumors: Current and Emerging Therapies. Malden, MA: Blackwell Science, 1999;137-149.
3. Strasberg SM, Howard TK, Molmenti EP, Hertl M. Selecting the donor liver: risk factors for poor function after orthotopic liver transplantation. HEPATOLOGY 1994;20:829-838.
4. Todo S, Demetris AJ, Makowka L, Teperman L, Podesta L, Shaver T, Tzakis A, et al. Primary nonfunction of hepatic allografts with preexisting fatty infiltration. Transplantation 1989;47:903-905.
5. Shirasugi N, Wakabayashi G, Shimazu M, Oshima A, Shito M, Kawachi S, Karahashi T, et al. Up-regulation of oxygen-derived free radicals by interleukin-1 in hepatic ischemia/reperfusion injury. Transplantation 1997;64: 1398-403.
6. Shito M, Wakabayashi G, Ueda M, Shimazu M, Shirasugi N, Endo M, Mukai M, et al. Interleukin 1 receptor blockade reduces tumor necrosis factor production, tissue injury, and mortality after hepatic ischemia-reperfusion in the rat. Transplantation 1997;63:143-148.
7. Hashimoto K, Nishizaki T, Yoshizumi T, Uchiyama H, Okano S, Ikegami T, Yanaga K, et al. Beneficial effect of FR167653 on cold ischemia/reperfusion injury in rat liver transplantation. Transplantation 2000;70:1318-1322.
8. Kobayashi J, Takeyoshi I, Ohwada S, Iwanami K, Matsumoto K, Muramoto M, Morishita Y. The effects of FR167653 in extended liver resection with ischemia in dogs. HEPATOLoGY 1998;28:459-465.
9. Yoshidome H, Kato A, Edwards MI, Lentsch AB. Interleukin-10 suppresses hepatic ischemia/reperfusion injury in mice: implications of a central role for nuclear factor kappaB. HEPATOLOGY 1999;30:203-208.
10. Yagihashi A, Hirata K, Zou XM, Tsuruma T, Araya J, Yajima T, Kameshima H, et al. Downregulation of cytokine-induced neutrophil chemoattractants and reduction of reperfusion injury in liver allograft by interleukin-10. Transplant Proc 2000;32:2302.
11. Zou XM, Hirata K, Nie G, Liang YW, Zhang JG, Qin HD, Zhang B. Investigation of rhIL-10 inhibition of acute rejection after liver transplantation. Transplant Proc 2000;32:2123-2124.
12. Le Moine O, Louis H, Demols A, Desalle F, Demoor F, Quertinmont E, Goldman M, et al. Cold liver ischemia-reperfusion injury critically depends on liver T cells and is improved by donor pretreatment with interleukin 10 in mice. HEPATOLOGY 2000;31:1266-1274.
13. Faggioni R, Fantuzzi G, Gabay C, Moser A, Dinarello CA, Feingold KR, Grunfeld C. Leptin deficiency enhances sensitivity to endotoxin-induced lethality. Am J Physiol 1999;276:R136-R142.
14. Yang SQ, Lin HZ, Lane MD, Clemens M, Diehl AM. Obesity increases sensitivity to endotoxin liver injury: implications for the pathogenesis of steatohepatitis. Proc Natl Acad Sci U S A 1997;94:2557-2562.
15. Serafin A, Rosello-Catafau J, Prats N, Xaus C, Gelpi E, Peralta C. Ischemic preconditioning increases the tolerance of fatty liver to hepatic ischemia-reperfusion injury in the rat. Am J Pathol 2002;161:587-601.
16. Liu P, Xu B, Spokas E, Lai PS, Wong PY. Role of endogenous nitric oxide in TNF-alpha and IL-1beta generation in hepatic ischemia-reperfusion. Shock 2000;13:217-223.
17. Liu P, Xu B, Hock CE. Inhibition of nitric oxide synthesis by L-name exacerbates acute lung injury induced by hepatic ischemia-reperfusion. Shock 2001;16:211-217.
18. Kim YM, Talanian RV, Li J, Billiar TR. Nitric oxide prevents IL-1 beta and IFN-gamma-inducing factor (IL-18) release from macrophages by inhibiting caspase-1 (IL-1 beta-converting enzyme). J Immunol 1998;161: 4122-4128.
19. Zingarelli B, Hake PW, Yang Z, O'Cormor M, Denenberg A, Wong HR. Absence of inducible nitric oxide synthase modulates early reperfusion-induced NF-kappaB and AP-1 activation and enhances myocardial damage. FASEB J 2002;16:327-342.
20. Bilbao G, Contreras JL, Eckhoff DE, Mikheeva G, Krasnykh V, Douglas JT, Thomas FT, et al. Reduction of ischemia-reperfusion injury of the liver by in vivo adenovirus-mediated gene transfer of the antiapoptotic Bcl-2 gene. Ann Surg 1999;230:185-193.
21. Selzner M, Rudiger HA, Sindram D, Madden J, Clavien PA. Mechanisms of ischemic injury are different in the steatotic and normal rat liver. HEPATOLOGY 2000;32:1280-1288.
22. Peralta C, Hotter G, Closa D, Gelpi E, Bulbena O, Rosello-Catafau J. Protective effect of preconditioning on the injury associated to hepatic ischemia-reperfusion in the rat: role of nitric oxide and adenosine. HEPATOLOGY 1997;25:934-937.
23. Masako I, Tadashi K, Koichi H, Hitoshi K, Minoru N, Takashi M. Beneficial effects of inducible nitric oxide synthase inhibitor on reperfusion injury in the pig liver. Transplantation 1999;68:803-813.
24. Kimura H, Katsuramaki T, Isobe M, Nagayama M, Meguro M, Kukita K, Nui A, et al. Role of inducible nitric oxide synthase in pig liver transplantation. J Surg Res 2003;111:28-37.
25. Long NC, Morimoto A, Nakamori T, Yamashiro O, Murakami N. Intraperitoneal injections of prostaglandin E2 attenuate hyperthermia induced by restraint or interleukin-1 in rats. J Physiol 1991;444:363-373.
26. Eppinger MJ, Ward PA, Bolling SF, Deeb GM. Regulatory effects of interleukin-10 on lung ischemia-reperfusion injury. J Thorac Cardiovasc Surg 1996;112:1301-1305.
27. Fukumura D, Miura S, Kurose I, Higuchi H, Suzuki H, Ebinuma H, Han JY, et al. IL-1 is an important mediator for microcirculatory changes in endotoxin-induced intestinal mucosal damage. Dig Dis Sci 1996;41: 2482-2492.
28. Reardon C, Sanchez A, Hogaboam CM, McKay DM. Tapeworm infection reduces epithelial ion transport abnormalities in murine dextran sulfatesodium-induced colitis. Infect Immun 2001;69:4417-4423.
29. Clark BD, Bedrosian I, Schindler R, Cominelli F, Cannon JG, Shaw AR, Dinarello CA. Detection of interleukin 1 alpha and 1 beta in rabbit tissues during endotoxemia using sensitive radioimmunoassays. J Appl Physiol 1991;71:2412-2418.
30. Jha HC, von Recklinghausen G, Zilliken F. Inhibition of in vitro microsomal lipid peroxidation by isoflavonoids. Biochem Pharmacol 1985;34: 1367-1369.
31. Camargo Jr CA, Madden JF, Gao W, Selvan RS, Clavien PA. Interleukin-6 protects liver against warm ischemia/reperfusion injury and promotes hepatocyte proliferation in the rodent. HEPATOLOGY 1997;26:1513-1520.
32. Shirasugi N, Wakabayashi G, Shimazu M, Shito M, Kawachi S, Kitajima M. Interleukin-1 receptor blockade attenuates oxygen-derived free radical production and microcirculatory, disturbances in ischemia/reperfusion injury in the liver. Transplant Proc 1997;29:371-373.
33. Bogdan C, Vodovotz Y, Nathan C. Macrophage deactivation by interleukin 10. J Exp Med 1991;174:1549-1555.
34. Peralta C, Closa D, Hotter G, Gelpi E, Prats N, Rosello-Catafau J. Liver ischemic preconditioning is mediated by the inhibitory action of nitric oxide on endothelin. Biochem Biophys Res Commun 1996;229:264-270.
35. 2 receptors. HEPATOLOGY 1999;29:126-132.
36. Peralta C, Fernandez-Zabalegui L, Panes J, Prats N, Sans M, Pique JM, Gelpi E, et al. Preconditioning protects against systemic disorders associated with hepatic ischemia-reperfusion through blockade of tumor necrosis factor-induced P-selectin up-regulation in the rat. HEPATOLOGY 2001;33: 100-113.
37. Kato A, Gabay C, Okaya T, Lentsch AB. Specific role of interleukin-1 in hepatic neutrophil recruitment after ischemia/reperfusion. Am J Pathol 2002;161:1797-1803.
38. Kato A, Okaya T, Lentsch AB. Endogenous IL-13 protects hepatocytes and vascular endothelial cells during ischemia/reperfusion injury. HEPATOLOGY 2003;37:304-312.
39. Carini R, De Cesaris MG, Splendore R, Vay D, Domenicotti C, Nitti MP, Paola D, et al. Signal pathway involved in the development of hypoxic preconditioning in rat hepatocytes. HEPATOLOGY 2001;33: 131-139.
40. Carini R, De Cesaris MG, Splendore R, Domenicotti C, Nitti MP, Pronzato MA, Albano E. Signal pathway responsible for hepatocyte preconditioning by nitric oxide. Free Radic Biol Med 2003;34:1047-1055.
41. Jiang JX, Zhang Y, Ji SH, Zhu P, Wang ZG. Kinetics of mitogen-activated protein kinase family in lipopolysaccharide-stimulated mouse Kupffer cells and their role in cytokine production. Shock 2002;18:336-341.
42. Ma W, Lim W, Gee K, Aucoin S, Nandan D, Kozlowski M, Diaz-Mitoma F, et al. The p38 mitogen-activated kinase pathway regulates the human interleukin-10 promoter via the activation of Sp1 transcription factor in lipopolysaccharide-stimulated human macrophages. J Biol Chem 2001; 27:13664-13674.